Open AccessRecurrence of endometrial cancer in a hysterectomised patient treated with tamoxifen for breast cancer: a case report
Author(s) -
James Woolas,
Megan M. Davis,
Siavash Rahimi
Publication year - 2020
Publication title -
journal of the royal society of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.38
H-Index - 81
eISSN - 1758-1095
pISSN - 0141-0768
DOI - 10.1177/0141076820961087
Subject(s) - tamoxifen , endometrial cancer , medicine , cancer , breast cancer , gynecology , oncology , general surgery
Tamoxifen exposure is a recognised risk for primary endometrial cancer. This case serves as a reminder to meticulously check the past medical history and inform patients of the risk-benefit of treatment as part of a shared-decision making process.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom